Skip to main content
×
×
Home

The outcomes of home treatment for schizophrenia

  • Hannah Chu Han Huang (a1), Mark Taylor (a2) (a3) (a4) and Alasdair Carmichael (a2)
Abstract
Aims and method

We examined whether intensive home treatment (IHTT) was beneficial for acute schizophrenia, using the Clinical Global Impression (CGI) scale as a measure of severity and change, between 2011–2015. Demographic and clinical details were collected.

Results

309 cases were referred to IHTT, comprising 245 separate individuals. This represented all severe acute psychotic episodes in Edinburgh during the study period. Three quarters of individuals had an improvement in CGI following IHTT and were safely managed at home. Thirty-nine per cent of all people received three or more regular medications. Comorbid drug and alcohol misuse was also frequently seen.

Clinical implications

IHTT can be beneficial to those suffering an acute episode of psychosis and has been shown to improve overall clinical outcome based on the CGI. Medication polypharmacy, as well as drug and alcohol use, are commonly seen in this population.

Declaration of interest

M.T. worked in IHTT at the time of the study, and has received fees and/or hospitality from Janssen, Lundbeck and Otsuka in the past 3 years.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      The outcomes of home treatment for schizophrenia
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      The outcomes of home treatment for schizophrenia
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      The outcomes of home treatment for schizophrenia
      Available formats
      ×
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike licence (http://creativecommons.org/licenses/by-nc-sa/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the same Creative Commons licence is included and the original work is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use.
Corresponding author
Correspondence to M. Taylor (marktaylor2@nhs.net)
References
Hide All
1Johnson, S. Crisis resolution and home treatment teams: an evolving model. Adv Psychiatr Treat 2013; 19(2): 115–23.
2McCrone, P, Johnson, S, Nolan, F, Pilling, S, Sandor, A, Hoult, J, et al. Economic evaluation of a crisis resolution service: a randomised controlled trial. Epidemiol Psichiatr Soc 2009; 18(1): 54–8.
3Barker, V, Taylor, M, Kader, I, Stewart, K, Le Fevre, P. Impact of crisis resolution and home treatment services on user experience and admission to psychiatric hospital. Psychiatrist 2011; 35(3): 106–10.
4Hopkins, C, Niemiec, S. Mental health crisis at home: service user perspectives on what helps and what hinders. J Psychiatr Ment Health Nurs. 2007; 14(3): 310–8.
5Whiteford, HA, Degenhardt, L, Rehm, J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 2013; 382(9904): 1575–86.
6Zipursky, RB, Menezes, NM, Streiner, DL. Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review. Schizophr Res 2014; 152: 408414.
7Ascher-Svanum, H, Zhu, B, Faries, DE, et al. The cost of relapse and the predictors of relapse in the treatment of schizophrenia. BMC Psychiatry 2010; doi: 10.1186/1471-244X-10-2.
8Hor, K, Taylor, M. Suicide and schizophrenia: a systematic review of rates and risk factors. J Psychopharmacol 2010; 24(4_supplement): 8190.
9Guy, W. Clinical Global Impressions (CGI) Scale, Modified. In Task Force for the Handbook of Psychiatric Measures. Handbook of Psychiatric Measures (1st ed.) (ed A John). American Psychiatric Association, 2000.
10Leucht, S, Kane, JM, Etschel, E, Kissling, W, Hamann, J, Engel, RR. Linking the PANSS, BPRS, and CGI: clinical implications. Neuropsychopharmacology 2006; 31(10): 2318–25.
11Chang, L, et al. Psychopathology, rehospitalization and quality of life among patients with schizophrenia under home care case management in Taiwan. Formosan Med Assoc 2013; 112: 208–15.
12Gomis, O, et al. Domiciliary intervention in psychosis: a systematic review. Actas Esp Psiquiatr 2017; 45(6): 290302.
13Patel, MX, Bishara, D, Jayakumar, S, et al. Quality of prescribing for schizophrenia: evidence from a national audit in England and Wales. Eur Neuropsychopharmacol 2014; 24(4): 499509.
14Langan, J, Shajahan, P. Antipsychotic polypharmacy: review of mechanisms, mortality and management. Psychiatrist 2010; 34(2): 5862.
15Fleischhacker, WW, Uchida, H. Critical review of antipsychotic polypharmacy in the treatment of schizophrenia. Int J Neuropsychopharmacol 2014; 17(7): 1083–93.
16Young, SL, Taylor, M, Lawrie, SM. ‘First do no harm.’ A systematic review of the prevalence and management of antipsychotic adverse effects. J Psychopharmacol 2015; 29: 353–62.
17Lacro, JP, Dunn, LB, Dolder, CR, Leckband, SG, Jeste, DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 2002; 63: 892909.
18Hartz, SM, Pato, CN, Medeiros, H, Cavazos-Rehg, P, Sobell, JL, Genomic Psychiatry Cohort Consortium (GPCC), et al. Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry 2014; 71(3): 248–54.
19Menezes, PR, Johnson, S, Thornicroft, G, et al. Drug and alcohol problems among individuals with severe mental illness in south London. Br J Psychiatry 1996; 168(5): 612–9.
20Ajetunmobi, O, Taylor, M, Stockton, D, Wood, R. Early death in those previously hospitalised for mental healthcare in Scotland: a nationwide cohort study, 1986–2010. BMJ Open 2013; 3(7): e002768.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Bulletin
  • ISSN: 2056-4694
  • EISSN: 2056-4708
  • URL: /core/journals/bjpsych-bulletin
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Type Description Title
WORD
Supplementary materials

Huang et al. supplementary material
Appendices

 Word (89 KB)
89 KB

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 389
Total number of PDF views: 57 *
Loading metrics...

Abstract views

Total abstract views: 192 *
Loading metrics...

* Views captured on Cambridge Core between 6th August 2018 - 17th August 2018. This data will be updated every 24 hours.

The outcomes of home treatment for schizophrenia

  • Hannah Chu Han Huang (a1), Mark Taylor (a2) (a3) (a4) and Alasdair Carmichael (a2)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *